Category: genetic testing

What Gets Measured Gets Done: Genomics, Surveillance Indicators and Healthy People 2020

graph

Public health surveillance indicators, such as those developed for the Healthy People initiative are useful for monitoring the development of genomic medicine in the United States. For several decades, Healthy People has established health benchmarks that are considered important metrics for tracking progress in health and healthcare in the United States. Read More >

Posted on by Muin J Khoury and Katherine Kolor, Office of Public Health Genomics, Centers for Disease Control and PreventionTags , , ,

Evidence Matters in Genomic Medicine- Round 2: Integrating Cancer Genomic Tests

stacked boxes with lettering

  In a previous blog, CDC’s Office of Public Health Genomics announced a list of health-related genomic tests and applications, stratified into three tiers according to the availability of scientific evidence and evidence-based recommendations as a result of systematic reviews.  The list is intended to promote information exchange and dialogue among researchers, providers, policy makers, and Read More >

Posted on by Michael P. Douglas and W. David Dotson, Office of Public Health Genomics, Centers for Disease Control and Prevention1 CommentTags , , ,

Think After You Spit: Personal Genomic Tests May Offer a Teachable Moment

Patient is showing physician her DTC genetic test results

Personal genomic tests are now widely available and sold directly to consumers, but population-based data are limited on awareness, use and impact of these tests. In collaboration with 4 state public health genomics programs, we have recently reported  on consumer awareness and use of personal genomic tests using the 2009 Behavioral Risk Factor Surveillance System. Read More >

Posted on by Muin J Khoury and Katherine Kolor, Office of Public Health Genomics, Centers for Disease Control and Prevention1 CommentTags , , ,

Workings of an Evidence-Based Genomic Panel

EGAPP logo

  Synopsis of the 24th Meeting of the Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group The EGAPP working group (EWG) has held 24 meetings in the 7 years since they were first convened; the latest EGAPP meeting was May 7-8, 2012 on the campus of CDC in Atlanta. Since it is Read More >

Posted on by W. David Dotson and Michael P. Douglas, Office of Public Health Genomics, Centers for Disease Control and PreventionTags , , , , , ,

Genomic Tests and Population Health: An Online Catalog to Promote a Conversation on Evolving Evidence

stacked boxed with A T C G on them

  With the rapid emergence of genomic tests, healthcare providers, patients and policy makers need to know how useful they are and whether the benefits of their use outweigh potential harms to patients, families, and the population. CDC’s Office of Public Health Genomics now offers a list of health-related genomic tests and applications, stratified into Read More >

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention4 CommentsTags , , , , ,

Evidence Matters in Genomic Medicine

EGAPP logo

A new IOM report makes recommendations that aim to ensure that progress in omics-based test development is grounded in sound scientific evidence and is reproducible, resulting in improved health care and continued public trust in research.  Another new IOM roundtable workshop report discussed the differences in evidence required for clinical use, regulatory oversight, guideline inclusion, coverage, Read More >

Posted on by Michael P. Douglas and W. David Dotson, Office of Public Health Genomics, Centers for Disease Control and Prevention1 CommentTags , ,

Making Universal Screening for Lynch Syndrome a Reality: The Lynch Syndrome Screening Network

flow chart individual

Every day, about 400 people in the United States are diagnosed with colorectal cancer. Approximately twelve of them have Lynch syndrome, a hereditary condition that increases the risk of colorectal cancer and other cancers.  Identifying people with Lynch syndrome could have substantial health benefits for them, their families, and communities.   Read More >

Posted on by Deb Duquette, MS, CGC & Sarah Mange, MPH- Michigan Department of Community Health; Cecelia Bellcross, PhD, MS- Emory University; Heather Hampel, MS, CGC- The Ohio State University; Kory Jasperson, MS, CGC- Huntsman Cancer Institute (Authors are all from the Lynch Syndrome Screening Network (LSSN) Founding Board of Directors)1 CommentTags , , , , ,

The Public Health Approach to Genetic Testing in the 21st Century: Saving Lives and Saving Unnecessary Healthcare Costs

vials on top of money

In March 2012, a prominent health insurer in the United States released a white paper entitled: “Personalized Medicine: trends and prospects for the new science of genetic testing and molecular diagnostics” By analyzing their own claims data, the report suggests that in 2010, the cost of genetic and molecular diagnostic testing for its members was about $500 Read More >

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention4 CommentsTags , , , ,

Emerging Evidence for the Benefits of Systematic Collection of Family History in Primary Care

a family

When it comes to the use of genomic tests and technologies in practice, Dr Al Berg is a skeptic. Dr Berg is the founding chair of the CDC-sponsored Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group that has been evaluating genomic tests for more than 5 years. He also chaired the National Institutes Read More >

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention3 CommentsTags , , ,

Think Before You Spit: Do Personal Genomic Tests Improve Health?

Think Before You Spit- a woman looking at a test tube

Campaigns against public spitting in the 19th century were largely driven by concerns about the spread of tuberculosis. However, at the beginning of the 21st century, spitting seems to be making a comeback.  Over the past few years, several companies have begun offering personal genomic tests online to the public. There have been famous images of Read More >

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention11 CommentsTags , ,